Immunogenicity and safety of vaccination against seasonal influenza vaccine in patients with psoriatic arthritis treated with secukinumab.

CONCLUSION: Secukinumab treatment does not affect the humoral response to influenza vaccine of patients with PsA.
PMID: 31767465 [PubMed - as supplied by publisher]

Source: Vaccine - November 21, 2019 Category: Allergy & Immunology Authors: Furer V, Zisman D, Kaufman I, Arad U, Berman M, Sarbagil-Maman H, Elias M, Hadad A, Paran D, Drori Y, Friedman N, Mandelboim M, Elkayam O Tags: Vaccine Source Type: research